Tvardi Therapeutics (TVRD) Shares Outstanding: 2013-2017
Historic Shares Outstanding for Tvardi Therapeutics (TVRD) over the last 5 years, with Sep 2017 value amounting to $32.6 million.
- Tvardi Therapeutics' Shares Outstanding rose 19.52% to $32.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was $32.6 million, marking a year-over-year increase of 19.52%. This contributed to the annual value of $27.3 million for FY2016, which is 0.15% up from last year.
- Per Tvardi Therapeutics' latest filing, its Shares Outstanding stood at $32.6 million for Q3 2017, which was up 0.13% from $32.6 million recorded in Q2 2017.
- Tvardi Therapeutics' 5-year Shares Outstanding high stood at $32.6 million for Q3 2017, and its period low was $4.3 million during Q1 2013.
- Moreover, its 3-year median value for Shares Outstanding was $27.3 million (2016), whereas its average is $27.4 million.
- Data for Tvardi Therapeutics' Shares Outstanding shows a peak YoY spiked of 431.73% (in 2014) over the last 5 years.
- Tvardi Therapeutics' Shares Outstanding (Quarterly) stood at $4.3 million in 2013, then surged by 431.73% to $22.8 million in 2014, then climbed by 19.53% to $27.3 million in 2015, then climbed by 0.15% to $27.3 million in 2016, then climbed by 19.52% to $32.6 million in 2017.
- Its last three reported values are $32.6 million in Q3 2017, $32.6 million for Q2 2017, and $27.3 million during Q1 2017.